IP Library Granted Patent US 10,507,233
Granted Patent B2
US 10,507,233 · App. 16/105,027 · Granted Dec 17, 2019

Universal N-glycan binding reagent

Inventors: Minyong Chen (Ipswich, MA); Xiaofeng Shi (Beverly, MA); James C. Samuelson (Newburyport, MA); Christopher H. Taron (Essex, MA)
Assignee: New England Biolabs, Inc.
A61K38/53C12N9/0006C12N9/1007C12N9/93C12N9/96C12Y201/01063C12Y603/02019C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,507,233
App. No.
16/105,027
Granted
Dec 17, 2019
Kind
B2
Abstract

Methods of capturing N-glycan linked glycomolecules including N-glycans, N-glycopeptides and N-glycoproteins are described. The methods provide substantially unbiased capture of charged and uncharged N-glycans and/or N-glycan linked glycomoleules. Binding reagents for substantially unbiased binding of N-glycans and/or N-glycan linked glycomolecules are also described.

Claims (8)

1. A protein comprising a non-naturally occurring amino acid sequence having at least 95% sequence identity to SEQ ID NO: 2 and mutations at least at two positions selected from positions that correspond to positions 42, 43, 44, 61, and 62 in SEQ ID NO:2.

2. The protein according to claim 1 , comprising an immobilization module to form a fusion protein.

3. The protein according to claim 1 , wherein the position of at least one of the at least two mutations are selected from positions corresponding to amino acid 43, 61, and 62.

4. The protein according to claim 1 , wherein the mutations at least at two positions are selected from a Proline (P) at a position corresponding to amino acid 42, an Alanine (A), Glycine (G) or Proline (P) at a position corresponding to amino acid 43, a Serine (S) or Arginine (R) at a position corresponding to amino acid 44, a Tyrosine (Y) at a position corresponding to amino acid 61 or an Arginine (R) at a position corresponding to amino acid 62.

5. The protein according to claim 3 , wherein the position of at least one of the at least two mutations are selected from positions corresponding to Alanine (A), Glycine (G) or Proline (P) at a position corresponding to amino acid 43, a Tyrosine (Y) at a position corresponding to amino acid 61 and an Arginine (R) at a position corresponding to amino acid 62.

6. The fusion protein according to claim 2 , wherein the immobilization module is a variant of O 6 -alkylguanine-DNA alkyltransferase (AGT).

7. The protein according to claim 4 , fused to an immobilization module.

8. The protein according to claim 7 , wherein the immobilization module is a variant of O 6 -alkylguanine-DNA alkyltransferase (AGT).

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2018
From: CHEN, MINYONG; SHI, XIAOFENG; SAMUELSON, JAMES C.; TARON, CHRISTOPHER H.
To: STRIMPEL, HARRIET M
Reel/Frame 047520/0852 →